Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-neuroinflammation Agent 1 effectively modulates BV2 microglia cell polarization, shifting from an M1 to an M2 phenotype [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | Anti-neuroinflammation Agent 1 effectively modulates BV2 microglia cell polarization, shifting from an M1 to an M2 phenotype [1]. |
| In vitro | Anti-neuroinflammation agent 1 (BMP 29) exhibited enhanced anti-neuroinflammatory activity without toxicity to BV2 microglial cells. In LPS-stimulated BV2 microglia, it significantly reduced M1 phenotype microglia, increased M2 phenotype, decreased pro-inflammatory cytokines (IL-18, IL-1β, TNF-α), increased anti-inflammatory cytokine (IL-10), inhibited NLRP3 inflammasome formation, and downregulated the M2 isoform of pyruvate kinase [1]. |
| In vivo | In mice, Anti-neuroinflammation Agent 1 (BMP 29) mitigates cuprizone-induced inflammation and demyelination by reducing the expression of inducible nitric oxide synthase, while simultaneously increasing the expression of CD206 [1]. |
| Molecular Weight | 523.86 |
| Formula | C22H20ClF6N3O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.